Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vladimir Dytrych"'
Publikováno v:
Biomedical Papers, Vol 165, Iss 2, Pp 157-161 (2021)
Aims. The primary objective of the registry was to assess the impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension (CTEPH) that was inoperable or persistent/recurrent after pulm
Externí odkaz:
https://doaj.org/article/f5a8d35dc23545e8a4aec3ef1b051c47
Autor:
Stepan Havranek, Zdenka Fingrova, Tomas Skala, Adrian Reichenbach, Milan Dusik, Pavel Jansa, David Ambroz, Vladimir Dytrych, Dalibor Klimes, Martin Hutyra, Josef Kautzner, Ales Linhart, Dan Wichterle
Publikováno v:
Europace.
Aims Atrial fibrillation (AF), typical atrial flutter (AFL), and other atrial tachycardias (ATs) are common in patients with pulmonary hypertension. Frequently, several supraventricular arrhythmias are successively observed in individual patients. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::828f8355cf5e920cb9d6c21bdd088836
https://doi.org/10.1093/europace/euad131
https://doi.org/10.1093/europace/euad131
Autor:
Lucie Miksová, Vladimír Dytrych, Václav Ptáčník, Martin Balík, Aleš Linhart, Jan Bělohlávek, Pavel Jansa
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 3, Pp n/a-n/a (2024)
Abstract COVID‐19 associates with a hypercoagulant state and an increased risk for venous thromboembolic events (VTEs). Whether severe COVID‐19 infection requiring extracorporeal membrane oxygenation (ECMO) support might lead to chronic pulmonary
Externí odkaz:
https://doaj.org/article/f5a36ebc2ffd479c92149ed19a381d24
Autor:
Pavel Jansa, David Ambrož, Matyáš Kuhn, Vladimír Dytrych, Michael Aschermann, Vladimír Černý, Virginie Gressin, Samuel Heller, Jan Kunstýř, Michal Širanec, Ci Song, Aleš Linhart, Jaroslav Lindner, Audrey Muller
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 1, Pp n/a-n/a (2022)
Abstract This study investigated the epidemiology and survival outcomes of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic, wherein pulmonary endarterectomy (PEA) surgery was the only targeted treatment option until 2015.
Externí odkaz:
https://doaj.org/article/adb586f84bd94dffa907c87d1415215e